Expression of chicken ovalbumin upstream promoter-transcription factor II enhances invasiveness of human lung carcinoma cells

Cancer Research

Volumn 64, Issue 15, 2004, Pages 5097-5105

  Navab, Roya ^a,b   Gonzalez Santos, Juana Maria ^a,b   Johnston, Michael R ^c   Liu, Jiang ^c   Brodt, Pnina ^d   Tsao, Ming Sound ^c   Hu, Jim ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; FOCAL ADHESION KINASE; GELATINASE A; METALLOPROTEINASE; UROKINASE;

ACTIN FILAMENT; ANGIOGENESIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACTINS; BLOTTING, WESTERN; COUP TRANSCRIPTION FACTOR II; COUP TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PLASMIDS; PROTEIN-TYROSINE KINASES; RECEPTORS, STEROID; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 3442877538     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1185     Document Type: Article

References (47)

1. Battle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat Cell Biol 2000;2:84-9.
2. Smirnov DA, Hou S, Liu X, Claudio E, Siebenlist UK, Ricciardi RP. COUP-TFII is up-regulated in adenovirus type 12 tumorigenic cells and is a repressor of MHC class I transcription. Virology 2001;284:13-9.
3. Navab R, Wang Y, Chow YH, et al. Regulation of human Clara cell 10 kD protein expression by chicken ovalbumin upstream promoter transcription factors (COUP-TFs). Am J Respir Cell Mol Biol 2002;27:273-85.
4. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members Annu Rev Biochem 1994;63:451-86.
5. Zhou C, Tsai SY, Tsai M. From apoptosis to angiogenesis: new insights into the roles of nuclear orphan receptors, chicken ovalbumin upstream promoter-transcription factors, during development. Biochim Biophys Acta 2000;1470:M63-8.
6. Kieback DG, Runnebaum IB, Moebus VJ, et al. Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines Gynecol Oncol 1993;51:167-70.
7. Kieback DG, Levi T, Kohlberger P, et al. Chicken ovalbumin upstream promoter-transcription factor (COUP-TF) expression in human endometrial cancer cell lines. Anticancer Res 1996;16:3371-6.
8. Wu Q, Li Y, Liu R, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J 1997;16:1656-69.
9. Shibata H, Ando T, Suzuki T, et al. Differential expression of an orphan receptor COUP-TFI and corepressors in adrenal tumors. Endocr Res 1998;24:881-5.
10. Kjoller L, Petersen HH, Andreasen PA. The urokinase-type plasminogen activator system in cancer metastasis: a review. Biochem J 1998;329:55-63.
11. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Annu Rev Physiol 1997;59:63-88.
12. Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG. Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging 1997;11:229-44.
13. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev. Biol 2001;17:463-516.
14. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
15. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Neurosci 2001;2:502-11.
16. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-73.
17. Henriet P, Blavier L, Declerck YA. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS 1999;107:111-9.
18. Goldberg GI, Manner BL, Grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Mine Med Off Assoc SA 1989;86:8207-11.
19. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-60.
20. Mazzieri R, Masiero L, Zanetta L, et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 1997;16:2319-32.
21. Montuori N, Mattiello A, Mancini A, et al. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. Int J Cancer 2003;105:353-60.
22. Li Y, Sarau HM, Nuthulaganti P, et al. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase. J Biol Chem 1996;271:20231-4.
23. Bugge TH, Kombrinck KW, Xiao Q, et al. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood 1997;90:4522-31.
24. Dumler I, Kopmann A, Weis A, et al. Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1999;19:290-7.
25. Liu J, Blackhall F, Long IS, et al. Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis. Oncogene;2004; in press.
26. Graham FL, Bacchetti S, McKinnon R, Stanners C, Cordell B, Goodman HM. Transformation of mammalian cells with DNA using the calcium technique. In: Baserga R, Croce C, Rovera G, editors. Introduction of macromolecules into viable mammalian cells. New York: Wiley-Liss; 1980. p. 3-25.
27. Nagahara H, Vocero-Akbani AM, Snyder EL, et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Genet 1998;4:1449-52.
28. Gonzalez-Santos JM, Wang A, Jones J, Ushida C, Liu J, Hu J. Central region of the human splicing factor Hprp3p interacts with Hprp4p. J Biol Chem 2002;277:23764-72.
29. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997;272:16010-7.
30. Navab R, Mort JS, Brodt P. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clin Exp Metastasis 1997;15:121-9.
31. Navab R, Chevet E, Authier F, Di Guglielmo GM, Bergeron JJ, Brodt P. Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. J Biol Chem 2001;276:13644-9.
32. Rigacci S, Rovida E, Sbarba PD, Berti A. Low Mr phosphotyrosine protein phosphatase associates and dephosphorylates p125 focal adhesion kinase, interfering with cell motilily and spreading. J Biol Chem 2002;277:41631-6.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nat Toxins 1970;227;680-5.
34. Lin B, Chen GQ, Xiao D, et al. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells. Mol Cell Biol 2000;20:957-70.
35. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988;55:1189-93.
36. Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 2001;11:41-7.
37. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 1999;13:1037-49.
38. Sawada M, Shii J, Akedo H, Tanizawa O. An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer. Lab Anim 1994;70:333-8,
39. Aguirre Ghiso JA. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 2002;21:2513-24.
40. Vassalli JD, Pepper MS. Tumour biology. Membrane proteases in focus. Nat Toxins 1994;370:14-5.
41. Le DM, Besson A, Fogg DK, et al. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neuroradiol 2003;23:4034-43.
42. Durko M, Brodt P. Suppression of type 1 collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor. Biochem Biophys Res Commun 1998;247:342-8.
43. Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983;695:177-214.
44. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 1994;269:32380-8.
45. Mohanam S, Chintala SK, Go Y, et al. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene 1997;14:1351-9.
46. Zhao JH, Reiske H, Guan JL. Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 1998;143:1997-2008.
47. Yu W, Kim J, Ossowski L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J Cell Biol 1997;137:767-77.